slides · global inventory
List Presentation
Tool collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 13,742
Current window 7,111-7,140
Pages 459
Rows per page 30
Tool
7,111-7,140 of 13,742
18
LumiraDx | Investor Presentation Deck | 55 slidesLumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
21
The slide uses a horizontal arrow at the bottom to represent the strategic shift toward 'Decentralization'.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
23
LumiraDx | Investor Presentation Deck | 55 slidesLumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
24
The slide uses a scatter plot to demonstrate method comparison between LumiraDx and a laboratory reference (bioMérieux Vidas).LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
26
The slide uses a bulleted list for key value propositions and a table to demonstrate clinical sensitivity (PPA) across different Ct value thresholds.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Evidence1 hit
29
The slide uses a process diagram to explain the workflow and a combination of line charts and a comparison table to demonstrate performance feasibility.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Evidence1 hit
41
The slide uses a process-like flow to categorize product applications.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
02
Morgan Stanley | Investment Banking Pitch Book | 30 slidesMorgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Situation & Context1 hit
16
The slide contains redacted text blocks. The structure suggests a hierarchical list of procedural steps.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Impact & Next Steps1 hit
17
The slide uses a bulleted list structure to organize communication steps, with redactions obscuring specific details.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Impact & Next Steps1 hit
05
Pathward Financial | Credit Presentation Deck | 39 slidesPathward Financial | Credit Presentation Deck | 39 slides · Pathward Financial
Pitch deck Investor relations Beat · The Ask1 hit
14
The slide uses a chronological progression to demonstrate R&D maturity and strategic focus on energy density and modularity.Proterra | Investor Presentation Deck | 28 slides · Proterra
Pitch deck Investor relations 1 hit
17
The slide uses a column-based layout to compare four distinct manufacturing sites.Proterra | Investor Presentation Deck | 28 slides · Proterra
Pitch deck Investor relations 1 hit
04
Reservoir | Investor Presentation Deck | 35 slidesReservoir | Investor Presentation Deck | 35 slides · Reservoir
Pitch deck Investor relations 1 hit
05
The slide uses a background image of the rap group Migos, likely to emphasize the company's focus on contemporary music and artist relationships.Reservoir | Investor Presentation Deck | 35 slides · Reservoir
Pitch deck Investor relations 1 hit
09
The slide uses a background watermark of a person's face. NPS stands for Net Publisher Share.Reservoir | Investor Presentation Deck | 35 slides · Reservoir
Pitch deck Investor relations 1 hit
11
LTM = Last Twelve Months. NLS = Net Label Share.Reservoir | Investor Presentation Deck | 35 slides · Reservoir
Pitch deck Investor relations 1 hit
08
The slide is partially obscured by a grey overlay, but the primary value proposition is clear.Roivant Sciences | Investor Presentation Deck | 21 slides · Immunovant
Pitch deck Investor relations 1 hit
14
The slide uses a comparative layout to differentiate two products in the company's pipeline.Roivant Sciences | Investor Presentation Deck | 21 slides · Immunovant
Pitch deck Investor relations 1 hit
03
SAB Biotherapeutics | Results Presentation Deck | 12 slidesSAB Biotherapeutics | Results Presentation Deck | 12 slides · SAB Biotherapeutics
Regulatory filing Investor relations 1 hit
06
Details the study sponsorship, location, participant demographics, dosing, and timeline.SAB Biotherapeutics | Results Presentation Deck | 12 slides · SAB Biotherapeutics
Regulatory filing Investor relations 1 hit
07
Clinical trial design disclosure.SAB Biotherapeutics | Results Presentation Deck | 12 slides · SAB Biotherapeutics
Regulatory filing Investor relations 1 hit
11
SAB Biotherapeutics | Results Presentation Deck | 12 slidesSAB Biotherapeutics | Results Presentation Deck | 12 slides · SAB Biotherapeutics
Regulatory filing Investor relations 1 hit
02
The slide highlights the impact of crypto market volatility on digital asset deposits versus growth in other banking divisions.Signature Bank | Results Presentation Deck | 3 slides · Signature Bank
Conference presentation Investor relations Beat · Interest1 hit
04
Skillsoft | Results Presentation Deck | 14 slidesSkillsoft | Results Presentation Deck | 14 slides · Skillsoft
Conference presentation Investor relations Beat · Interest1 hit
04
The slide outlines a financial challenge (funding gap) and specific operational strategies to address it.SkyHarbour | Investor Presentation Deck | 8 slides · SkyHarbour
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
SkyHarbour | Investor Presentation Deck | 8 slidesSkyHarbour | Investor Presentation Deck | 8 slides · SkyHarbour
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
03
TCR2 Therapeutics | Results Presentation Deck | 34 slidesTCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · Problem1 hit
04
Includes a list of abbreviations at the bottom.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · Problem1 hit
15
The slide uses a process diagram to illustrate the dose escalation cohorts leading to the Recommended Phase 2 Dose (RP2D).TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit